Introduction to story boarding

submitted by: kpezzoli

slides with templates

Proton therapy treatment for glioblastoma

submitted by: mdanderson

Glioblastoma multiforme is one of the toughest brain tumors to treat and also is one of the most aggressive. Paul Brown, M.D., professor in Radiation Oncology at MD Anderson Cancer Center, discusses a ground-breaking clinical trial that treats glioblastoma with intensity modulated proton therapy (IMPT). Also in this podcast, Brown explains other new discoveries in adult and childhood brain cancer research and the importance of a skilled proton therapy center.

Novel cell-based and materials science approach to target Glioblastoma brain cancer tumors

submitted by: nsf

Stefan Bossmann and Deryl Troyer at Kansas State University are developing a novel materials treatment method for persons with brain cancer that uses a type of white blood cell to deliver anticancer drugs to particularly virulent brain tumors.

Smokers with HIV/AIDS find quitting easier with cell phone counseling

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/smokers-hiv-aids-find-quitting/id43... A smoking-cessation intervention delivered through mobile phones to smokers who are HIV/AIDS positive has a better success rate compared to standard treatment. Listen to Ellen Gritz, Ph.D., professor and chair, and Damon Vidrine, Dr.P.H., assistant professor, both in Behavioral Science at MD Anderson Cancer Center, discuss their research findings.

Young breast cancer patients with early-stage disease may undergo unnecessary testing when diagnosed

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/young-breast-cancer-patients/id4318... . More than one third of younger, early stage breast cancer patients undergo unnecessary imaging procedures – including position emission tomography (PET), computed tomography (CT), nuclear medicine bone scans (NMBS) and tumor markers (TM) -- at the time of staging and diagnosis. Carlos Barcenas, M.D., assistant professor, Breast Medical Oncology and Sharon Giordano, M.D., professor, Breast...

Breast cancer – most common cancer in women

submitted by: mdanderson
Download: https://itunes.apple.com/us/itunes-u/breast-cancer-most-common/id4318482... Breast cancer has two main types: ductal carcinoma and lobular carcinoma. These two types of breast cancer present and behave differently but they are treated the same way. Sharon Giordano, M.D., professor in Breast Medical Oncology at The University of Texas MD Anderson Cancer Center and chair of Health Services Research, discusses the differences between ductal and lobular carcinomas including in situ...

Appendix cancer – alternatives to surgery

submitted by: mdanderson
Download from itunes: https://itunes.apple.com/us/itunes-u/appendix-cancer-alternatives/id4318... . If appendix cancer is found early, surgery is the standard of care. Alternatives to surgery are available for advanced appendix cancer, but more data is needed to accurately treat this rare form of cancer. Cathy Eng, M.D., associate professor of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, discusses options for non-surgical candidates including hyperthermic...

Chronic Lymphocytic Leukemia CLL Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveres into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Michael Keating, M.D., professor in MD Anderson's Leukemia...

Melanoma Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Jeffrey Gershenwald, M.D., professor in MD Anderson's...

Prostate Cancer Moon Shot Annual Report 2013

submitted by: mdanderson
The University of Texas MD Anderson Cancer Center in September 2012 launched its Moon Shots Program, an ambitious and comprehensive action plan to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. Initial moon shot cancers are breast and ovarian; acute myeloid leukemia and myelodysplastic syndromes; chronic lymphocytic leukemia; lung; melanoma and prostate cancer. Christopher Logothetis, M.D., chair and professor,...